Why the study?
The study evaluated whether the CHA2DS2-VASc score could predict relevant CAD leading to PCI and all-cause mortality after detected ventricular arrhythmia in patients with an ICD.
Does the CHA2DS2-VASc score predict relevant CAD leading to PCI and all-cause mortality in ICD patients after detected ventricular arrhythmia?
Does the CHA2DS2-VASc score predict relevant CAD leading to PCI and all-cause mortality in ICD patients after detected ventricular arrhythmia?
The CHA2DS2-VASc score can be used as a prognostic tool to predict CAD progression requiring PCI and 3-year all-cause mortality in ICD patients following a ventricular arrhythmia.
Answers are grounded in this paper and cite their sources.
May support CHA2DS2-VASc for mortality prognostication in ICD patients post-arrhythmia; hypothesis-generating and requires prospective validation.
AIM: -VASC score as a risk assessment tool to predict relevant coronary artery disease (CAD) leading to percutaneous coronary intervention (PCI), and all-cause mortality after detected ventricular arrhythmia (VA) in patients with an Implantable Cardioverter-Defibrillator (ICD). ICD-Patients with a high score have an increased risk for reduced three-year all-cause mortality after VA.
No takes yet. Share an insight, caveat, or question.
Kavsur et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: